Cargando…
Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590842/ https://www.ncbi.nlm.nih.gov/pubmed/34805808 http://dx.doi.org/10.1016/j.eclinm.2021.101203 |
_version_ | 1784599075423780864 |
---|---|
author | Blum, Vinicius Fontanesi Cimerman, Sérgio Hunter, James R Tierno, Paulo Lacerda, Acioly Soeiro, Alexandre Cardoso, Florentino Bellei, Nancy Cristina Maricato, Juliana Mantovani, Nathalia Vassao, Marcella Dias, Danilo Galinskas, Juliana Janini, Luis Mário Ramos Santos-Oliveira, Joanna Reis Da-Cruz, Alda Maria Diaz, Ricardo Sobhie |
author_facet | Blum, Vinicius Fontanesi Cimerman, Sérgio Hunter, James R Tierno, Paulo Lacerda, Acioly Soeiro, Alexandre Cardoso, Florentino Bellei, Nancy Cristina Maricato, Juliana Mantovani, Nathalia Vassao, Marcella Dias, Danilo Galinskas, Juliana Janini, Luis Mário Ramos Santos-Oliveira, Joanna Reis Da-Cruz, Alda Maria Diaz, Ricardo Sobhie |
author_sort | Blum, Vinicius Fontanesi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8590842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-85908422021-11-15 Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] Blum, Vinicius Fontanesi Cimerman, Sérgio Hunter, James R Tierno, Paulo Lacerda, Acioly Soeiro, Alexandre Cardoso, Florentino Bellei, Nancy Cristina Maricato, Juliana Mantovani, Nathalia Vassao, Marcella Dias, Danilo Galinskas, Juliana Janini, Luis Mário Ramos Santos-Oliveira, Joanna Reis Da-Cruz, Alda Maria Diaz, Ricardo Sobhie EClinicalMedicine Corrigendum Elsevier 2021-11-14 /pmc/articles/PMC8590842/ /pubmed/34805808 http://dx.doi.org/10.1016/j.eclinm.2021.101203 Text en © 2021 The Authors |
spellingShingle | Corrigendum Blum, Vinicius Fontanesi Cimerman, Sérgio Hunter, James R Tierno, Paulo Lacerda, Acioly Soeiro, Alexandre Cardoso, Florentino Bellei, Nancy Cristina Maricato, Juliana Mantovani, Nathalia Vassao, Marcella Dias, Danilo Galinskas, Juliana Janini, Luis Mário Ramos Santos-Oliveira, Joanna Reis Da-Cruz, Alda Maria Diaz, Ricardo Sobhie Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
title | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
title_full | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
title_fullStr | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
title_full_unstemmed | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
title_short | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
title_sort | corrigendum to “nitazoxanide superiority to placebo to treat moderate covid-19 – a pilot prove of concept randomized double-blind clinical trial.” [eclinicalmedicine 37 (2021) 100981] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590842/ https://www.ncbi.nlm.nih.gov/pubmed/34805808 http://dx.doi.org/10.1016/j.eclinm.2021.101203 |
work_keys_str_mv | AT blumviniciusfontanesi corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT cimermansergio corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT hunterjamesr corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT tiernopaulo corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT lacerdaacioly corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT soeiroalexandre corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT cardosoflorentino corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT belleinancycristina corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT maricatojuliana corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT mantovaninathalia corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT vassaomarcella corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT diasdanilo corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT galinskasjuliana corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT janiniluismarioramos corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT santosoliveirajoannareis corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT dacruzaldamaria corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT diazricardosobhie corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 |